Table 2 Response evaluation 0.24 mg/kg/d... | American Society of Hematology

Table 2

Response evaluation 0.24 mg/kg/d cohort by treatment indication (N = 46)

	N	Responses		Treatment failure			Response rate, %
	N	CR	CRi	Persistent leukemia	Death during aplasia	Unknown	CR + CRi	CR only
First relapse, first salvage, total	32	15	3	12	1	0	56	47
CR1 < 6 mo	11	2	1	7	0	1	27	18
First salvage, CR1 6-12 mo	11	5	2	4	0	0	64	45
First salvage, CR1 > 12 mo	10	8	0	1	1	0	80	80
Primary refractory, total	10	2	0	6	2	0	20	20
1 induction	8	2	0	5	1	0	25	25
≥ 2 inductions	2	0	0	1	1	0	0	0
≥ Second relapse /salvage	4	1	0	3	0	0	25	25
Total	46	18	3	21	3	1	46	39

	N	Responses		Treatment failure			Response rate, %
	N	CR	CRi	Persistent leukemia	Death during aplasia	Unknown	CR + CRi	CR only
First relapse, first salvage, total	32	15	3	12	1	0	56	47
CR1 < 6 mo	11	2	1	7	0	1	27	18
First salvage, CR1 6-12 mo	11	5	2	4	0	0	64	45
First salvage, CR1 > 12 mo	10	8	0	1	1	0	80	80
Primary refractory, total	10	2	0	6	2	0	20	20
1 induction	8	2	0	5	1	0	25	25
≥ 2 inductions	2	0	0	1	1	0	0	0
≥ Second relapse /salvage	4	1	0	3	0	0	25	25
Total	46	18	3	21	3	1	46	39

CRi indicates complete remission with incomplete blood count recovery.